Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:associated_with |
Autoimmune diseases
Respiratory infections Chronic fatigue syndrome Immunocompromised patients |
| gptkbp:cause |
gptkb:Roseola
|
| gptkbp:clinical_trial |
Conducted for treatment options
Mild in healthy individuals Potentially causes encephalitis |
| gptkbp:community_health |
Limited awareness
|
| gptkbp:complications |
Febrile seizures
|
| gptkbp:data_usage |
Increased in close contact
|
| gptkbp:diagnosis |
PCR
Serological assays Similar symptoms to other infections |
| gptkbp:discovered_by |
gptkb:1990
|
| gptkbp:diseases |
gptkb:Yes
gptkb:Exanthem_subitum Common with other herpesviruses Low in immunocompetent hosts |
| gptkbp:epidemiology |
Worldwide distribution
|
| gptkbp:family |
gptkb:Herpesviridae
|
| gptkbp:funding |
Available for studies
|
| gptkbp:genetic_diversity |
Exists among strains
|
| gptkbp:genus |
gptkb:Roseolovirus
|
| gptkbp:grooming_needs |
Higher in acute phase
Occurs in saliva |
| https://www.w3.org/2000/01/rdf-schema#label |
Human herpesvirus 7
|
| gptkbp:immune_response |
Cell-mediated immunity
|
| gptkbp:infection_prevention |
Good hygiene practices
|
| gptkbp:infection_route |
Horizontal transmission
|
| gptkbp:is_compared_to |
Over 90% in adults
|
| gptkbp:is_part_of |
gptkb:Herpesviridae
|
| gptkbp:is_vulnerable_to |
No
|
| gptkbp:originated_in |
gptkb:T_cells
|
| gptkbp:prevalence |
Common in childhood
|
| gptkbp:propagation_method |
Saliva
|
| gptkbp:provides_guidance_on |
Not well established
|
| gptkbp:related_to |
gptkb:Human_herpesvirus_6
|
| gptkbp:replaces |
Human blood
|
| gptkbp:research |
Ongoing
|
| gptkbp:research_focus |
Viral pathogenesis
|
| gptkbp:seed_dispersal |
Double-stranded DNA
|
| gptkbp:serological_tests |
Ig G and Ig M detection
|
| gptkbp:subfamily |
gptkb:Betaherpesvirinae
|
| gptkbp:symptoms |
gptkb:Fever
Rash Lymphadenopathy |
| gptkbp:treatment |
Antiviral medication
Variable Symptomatic relief Generally favorable in healthy individuals Investigating new antiviral agents Limited antiviral options |
| gptkbp:viral_infection |
Common in early childhood
|
| gptkbp:viral_infections |
Can be asymptomatic
|
| gptkbp:viral_persistence |
Can occur in host cells
|
| gptkbp:viral_reactivation |
Possible in immunocompromised individuals
|
| gptkbp:bfsParent |
gptkb:Herpesviridae
|
| gptkbp:bfsLayer |
6
|